COMBINATION OF AN MEK INHIBITOR AND THE SRC KINASE INHIBITOR AZD0530 FOR USE IN THE TREATMENT OF CANCER
The invention relates to a combination for use in the treatment of cancer comprising a MEK inhibitor and the Src kinase inhibitor AZD0530.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
26.11.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!